Patents have helped promote innovation for centuries, but themodern application of patents to the field of medicine raiseslegal and ethical questions. Patents covering pharmaceuticalproducts and medical research tools are ubiquitous, and manydiscoveries described by such patents have contributed to theadvancement of medical science. At the same time, when patentprotection has been too broad, extended beyond the term initiallygranted, or granted for discoveries that are far from groundbreaking,it has hindered scientific progress and increased costs in themedical marketplace. A wide-ranging debate has emerged overhow to balance these competing interests.1,2,3
Implications of Process Patents for Clinical Medicine
Source Information
From the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital (A.S.K.), and the Department of Health Policy and Management, Harvard School of Public Health (M.M.M.) both in Boston.
Vecht, J. A., Athanasiou, T., Ashrafian, H., Mayer, E., Darzi, A., von Segesser, L. K.
(2009). Surgeons produce innovative ideas which are frequently lost in the labyrinth of patents. Eur. J. Cardiothorac. Surg.
35: 480-488
[Abstract][Full Text]
RELMAN, A. S.
(2008). Medical professionalism in a commercialized health care market. Cleveland Clinic Journal of Medicine
75: S33-S36
[Full Text]
Klein, R. D., Mahoney, M. J.
(2008). LabCorp v. Metabolite Laboratories: The Supreme Court Listens, but Declines to Speak.. J Law Med Ethics
36: 141-149
Klein, R. D.
(2007). Medical-Process Patents. NEJM
356: 753-754
[Full Text]